TRICUSPID REGURGITATION (TR)
Clinical trials for TRICUSPID REGURGITATION (TR) explained in plain language.
Never miss a new study
Get alerted when new TRICUSPID REGURGITATION (TR) trials appear
Sign up with your email to follow new studies for TRICUSPID REGURGITATION (TR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New artificial heart valve could help patients too sick for surgery
Disease control OngoingThis trial tests a new artificial valve, called LuX-Valve Plus, for people with severe tricuspid regurgitation (a leaky heart valve) who are not candidates for open-heart surgery. Participants are randomly assigned to receive either the valve implant plus standard medical therapy…
Matched conditions: TRICUSPID REGURGITATION (TR)
Phase: NA • Sponsor: Jenscare Scientific • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New valve device offers hope for High-Risk heart patients
Disease control OngoingThis study tests a new device called LuX-Valve Plus, which is a replacement heart valve delivered through a vein, for people with severe tricuspid regurgitation (a leaky heart valve). The 15 participants have symptoms and are not candidates for surgery. The goal is to see if the …
Matched conditions: TRICUSPID REGURGITATION (TR)
Phase: NA • Sponsor: Jenscare Innovation Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC